Dissecting the immune cell mayhem that drives lupus pathogenesis

Science Translational Medicine

Volumn 3, Issue 73, 2011, Pages

  Craft, Joseph E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; AUTOANTIGEN; CD154 ANTIBODY; CD40 LIGAND; CLOPIDOGREL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOKINE; DNA BINDING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; IMMUNOSTIMULATION; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE; THROMBOEMBOLISM; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD; IMMUNOLOGY; NEUTROPHIL; NOTE; THROMBOCYTE ACTIVATION;

AUTOANTIBODIES; BLOOD PLATELETS; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MODELS, IMMUNOLOGICAL; NEUTROPHILS; PLATELET ACTIVATION;

EID: 79952465573     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3002138     Document Type: Review

References (42)

1. M. J. Shlomchik, J. E. Craft, M. J. Mamula, From T to B and back again: Positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1, 147-153 (2001).
2. I. T. Harley, K. M. Kaufman, C. D. Langefeld, J. B. Harley, J. A. Kelly, Genetic susceptibility to SLE: New insights from fine mapping and genome-wide association studies. Nat. Rev. Genet. 10, 285-290 (2009).
3. R. Lande, D. Ganguly, V. Facchinetti, L. Frasca, C. Conrad, J. Gregorio, S. Meller, G. Chamilos, R. Sebasigari, V. Riccieri, R. Bassett, H. Amuro, S. Fukuhara, T. Ito, Y.-J. Liu, M. Gilliet, Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra19 (2011).
4. G. S. Garcia-Romo, S. Caielli, B. Vega, J. Connolly, F. Allantaz, Z. Xu, M. Punaro, J. Baisch, C. Guiducci, R. L. Coffman, F. J. Barrat, J. Banchereau, V. Pascual, Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra20 (2011).
5. P. Duffau, J. Seneschal, C. Nicco, C. Richez, E. Lazaro, I. Douchet, C. Bordes, J.-F. Viallard, C. Goulvestre, J.-L. Pellegrin, B. Weil, J.-F. Moreau, F. Batteux, P. Blanco, Platelet CD154 potentiates interferon-α secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci. Transl. Med. 2, 47ra63 (2010).
6. A. Bergtold, A. Gavhane, V. D'Agati, M. Madaio, R. Clynes, FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J. Immunol. 177, 7287-7295 (2006).
7. L. Schiffer, J. Sinha, X. Wang, W. Huang, G. von Gersdorff, M. Schiffer, M. P. Madaio, A. Davidson, Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J. Immunol. 171, 489-497 (2003).
8. E. A. Leadbetter, I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, A. Marshak-Rothstein, Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607 (2002).
9. L. A. DeGiorgio, K. N. Konstantinov, S. C. Lee, J. A. Hardin, B. T. Volpe, B. Diamond, A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7, 1189-1193 (2001).
10. O. T. Chan, L. G. Hannum, A. M. Haberman, M. P. Madaio, M. J. Shlomchik, A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189, 1639-1648 (1999).
11. J. J. Hooks, H. M. Moutsopoulos, S. A. Geis, N. I. Stahl, J. L. Decker, A. L. Notkins, Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301, 5-8 (1979).
12. O. T. Preble, R. J. Black, R. M. Friedman, J. H. Klippel, J. Vilcek, Systemic lupus erythematosus: Presence in human serum of an unusual acid-labile leukocyte interferon. Science 216, 429-431 (1982).
13. S. R. Ytterberg, T. J. Schnitzer, Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum. 25, 401-406 (1982).
14. A. A. Bengtsson, G. Sturfelt, L. Truedsson, J. Blomberg, G. Alm, H. Vallin, L. Rönnblom, Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9, 664-671 (2000).
15. L. Bennett, A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, V. Pascual, Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197, 711-723 (2003).
16. E. C. Baechler, F. M. Batliwalla, G. Karypis, P. M. Gaffney, W. A. Ortmann, K. J. Espe, K. B. Shark, W. J. Grande, K. M. Hughes, V. Kapur, P. K. Gregersen, T. W. Behrens, Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U.S.A. 100, 2610-2615 (2003).
17. P. Blanco, A. K. Palucka, M. Gill, V. Pascual, J. Banchereau, Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294, 1540-1543 (2001).
18. G. Jego, A. K. Palucka, J. P. Blanck, C. Chalouni, V. Pascual, J. Banchereau, Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19, 225-234 (2003).
19. M. Cella, D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, A. Lanzavecchia, M. Colonna, Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5, 919-923 (1999).
20. F. P. Siegal, N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, Y. J. Liu, The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837 (1999).
21. + dendritic cells. J. Immunol. 166, 5000-5007 (2001).
22. A. Krug, S. Rothenfusser, V. Hornung, B. Jahrsdörfer, S. Blackwell, Z. K. Ballas, S. Endres, A. M. Krieg, G. Hartmann, Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells. Eur. J. Immunol. 31, 2154-2163 (2001).
23. B. Cederblad, S. Blomberg, H. Vallin, A. Perers, G. V. Alm, L. Rönnblom, Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. J. Autoimmun. 11, 465-470 (1998).
24. F. J. Barrat, T. Meeker, J. Gregorio, J. H. Chan, S. Uematsu, S. Akira, B. Chang, O. Duramad, R. L. Coffman, Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202, 1131-1139 (2005).
25. T. B. Niewold, J. A. Kelly, M. H. Flesch, L. R. Espinoza, J. B. Harley, M. K. Crow, Association of the IRF5 risk haplotype with high serum interferon-α activity in systemic lupus erythematosus patients. Arthritis Rheum. 58, 2481-2487 (2008).
26. R. A. Eisenberg, S. Y. Craven, R. W. Warren, P. L. Cohen, Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J. Clin. Invest. 80, 691-697 (1987).
27. V. Brinkmann, U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, D. S. Weiss, Y. Weinrauch, A. Zychlinsky, Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535 (2004).
28. V. Papayannopoulos, K. D. Metzler, A. Hakkim, A. Zychlinsky, Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 191, 677-691 (2010).
29. R. Lande, J. Gregorio, V. Facchinetti, B. Chatterjee, Y. H. Wang, B. Homey, W. Cao, Y. H. Wang, B. Su, F. O. Nestle, T. Zal, I. Mellman, J. M. Schröder, Y. J. Liu, M. Gilliet, Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569 (2007).
30. D. Ganguly, G. Chamilos, R. Lande, J. Gregorio, S. Meller, V. Facchinetti, B. Homey, F. J. Barrat, T. Zal, M. Gilliet, Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206, 1983-1994 (2009).
31. F. J. Barrat, R. L. Coffman, Development of TLR inhibitors for the treatment of autoimmune diseases. Immunol. Rev. 223, 271-283 (2008).
32. C. Guiducci, M. Gong, Z. Xu, M. Gill, D. Chaussabel, T. Meeker, J. H. Chan, T. Wright, M. Punaro, S. Bolland, V. Soumelis, J. Banchereau, R. L. Coffman, V. Pascual, F. J. Barrat, TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 465, 937-941 (2010).
33. S. A. Quezada, L. Z. Jarvinen, E. F. Lind, R. J. Noelle, CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22, 307-328 (2004).
34. S. Agarwal, J. R. Elliott, S. Manzi, Atherosclerosis risk factors in systemic lupus erythematosus. Curr. Rheumatol. Rep. 11, 241-247 (2009).
35. J. E. Joseph, P. Harrison, I. J. Mackie, D. A. Isenberg, S. J. Machin, Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br. J. Haematol. 115, 451-459 (2001).
36. M. A. Petri, A. N. Kiani, W. Post, L. Christopher-Stine, L. S. Magder, Lupus Atherosclerosis Prevention Study (LAPS), Lupus Atherosclerosis Prevention Study (LAPS). Ann. Rheum. Dis. (2010). 10.1136/ard.2010.136762
37. O. A. Chow, M. von Köckritz-Blickwede, A. T. Bright, M. E. Hensler, A. S. Zinkernagel, A. L. Cogen, R. L. Gallo, M. Monestier, Y. Wang, C. K. Glass, V. Nizet, Statins enhance formation of phagocyte extracellular traps. Cell Host Microbe 8, 445-454 (2010).
38. A. C. Grammer, R. Slota, R. Fischer, H. Gur, H. Girschick, C. Yarboro, G. G. Illei, P. E. Lipsky, Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. J. Clin. Invest. 112, 1506-1520 (2003).
39. A. L. Peters, L. L. Stunz, G. A. Bishop, CD40 and autoimmunity: The dark side of a great activator. Semin. Immunol. 21, 293-300 (2009).
40. M. F. Gourley, H. A. Austin 3rd, D. Scott, C. H. Yarboro, E. M. Vaughan, J. Muir, D. T. Boumpas, J. H. Klippel, J. E. Balow, A. D. Steinberg, Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann. Intern. Med. 125, 549-557 (1996).
41. E. M. Ginzler, M. A. Dooley, C. Aranow, M. Y. Kim, J. Buyon, J. T. Merrill, M. Petri, G. S. Gilkeson, D. J. Wallace, M. H. Weisman, G. B. Appel, Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N. Engl. J. Med. 353, 2219-2228 (2005).
42. Funding: Supported in part by NIH grants R01 AR40072, R01 AR44076, 5 R01 AI075157, and P30 AR053495 and by Rheuminations, Inc., and the Alliance for Lupus Research.